MANGALAM DRUGS & ORGANICS LTD. - Results-Unaudited Financial Results For The Quarter Ended June 30, 2022

Download	< Back
05 Aug 2022
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)
View all announcements for MANGALAM DRUGS & ORGANICS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2022	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Mutual Fund Selector